http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-200630340-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-79 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-00 |
| filingDate | 2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da837ca5d802695397e3d4a54664646d |
| publicationDate | 2006-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-200630340-A |
| titleOfInvention | Process for preparation of isonicotinic acid derivatives |
| abstract | The present invention relates to a process for the manufacture of compounds of formula Ia or Ib, and pharmaceutically acceptable additional salts thereof, wherein R is lower Alkyl. The compounds of formula Ia or Ib are valuable intermediate products for the manufacture of compounds which are pharmaceutically active as adenosine A2a receptor antagonist or metabotropic Glutamate receptor 2 antagonist. They are important in the regulation of many aspects of cellular metabolism and in the modulation of different central nervous system activities. |
| priorityDate | 2004-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.